Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
deals
3
×
life sciences
national blog main
national top stories
startups
3
×
boston
boston top stories
clinical trials
new york blog main
new york top stories
san francisco blog main
san francisco top stories
sanofi
sickle cell disease
abbvie
akouos
allergan
allosteric
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
atlas venture
atopic dermatitis
autoimmune disorders
azacitidine
beta-thalassemia
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
brace pharma
cancer
cancer immunotherapy
cerovene
cleva pharma
covid-19
What
medicines
3
×
new
therapeutics
years
acquisitions
address
adds
ago
aims
allosteric
announced
approach
based
bio
biotech
called
ceo
clinic
collabs
covid
daniel
deal
debuts
developing
disease
drugs
elusive
epigenetic
epigenetics
field
flagship’s
gilead
gilead’s
help
hotspot
introduce
ipo
molecules
month
morning
Language
unset
3
×
Current search:
unset
×
startups
×
medicines
×
deals
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further